Who Supplies Osimertinib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Osimertinib exports, with 15+ registered manufacturers shipping to buyers across 8+ countries — yet a handful of companies dominate the shipments. NU HOSPITALS PRIVATE LIMITED holds the largest share at 24.2% (export value: $264.1K). Close behind, NIVIRA EXPORTS (18.6%, $202.9K). IKRIS PHARMA NETWORK PRIVATE LIMITED (12.0%, $130.8K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Osimertinib? Top Manufacturers & Their Buyers
Flow of Osimertinib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Osimertinib Supplier Network — Key Market Intelligence
The Osimertinib export market from India is led by NU HOSPITALS PRIVATE LIMITED, which alone commands a 24.2% share, shipping $264.1K worth of product across 4 shipments. The second-largest exporter, NIVIRA EXPORTS, contributes $202.9K (18.6%) to the overall market. Combined, the top two suppliers alone account for 42.8% of all Osimertinib exports, indicating a relatively concentrated supply base.
Across all 15 tracked manufacturers, the total Osimertinib export value stands at $1.1M from 130 shipments. The market average shipment value is $8.4K. The single largest buyer relationship in terms of trade value is INDIRA GANDHI MEMORIAL HOSPITAL, receiving $130.8K worth of product.
The combined buyer network spans 11 named purchasing companies, including TO THE CONCERN PERSON, CONCERN PERSON WANILDA DE, GUILHERME MARTINS DE ALMEIDA, LUIZ FRANCISCO GENRO SCHORN, MARGARIDA ALVES DE SOUSA and 6 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1NU HOSPITALS PRIVATE LIMITED
NU HOSPITALS PRIVATE LIMITED is the first-largest Osimertinib exporter from India, with a market share of 24.2% and a total export value of $264.1K across 4 shipments. Their average shipment value of $66.0K is above the market average of $8.4K, suggesting premium or bulk contract pricing.
NU HOSPITALS PRIVATE LIMITED serves 1 named buyer in our database. FOR THE ORDER OF is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• FOR THE ORDER OF — $264.1K across 4 shipments (100.0% of this supplier's total exports)
Key Insight: NU HOSPITALS PRIVATE LIMITED's per-shipment value of $66.0K is 687% above the market average of $8.4K, consistent with large-order contracts or value-added formulations.
2NIVIRA EXPORTS
NIVIRA EXPORTS is the second-largest Osimertinib exporter from India, with a market share of 18.6% and a total export value of $202.9K across 52 shipments. Their average shipment value of $3.9K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
NIVIRA EXPORTS serves 5 named buyers in our database. TO THE CONCERN PERSON is the dominant customer, accounting for 61.8% of this supplier's tracked business. Top customers include:
• TO THE CONCERN PERSON — $125.4K across 32 shipments (61.8% of this supplier's total exports)
• CONCERN PERSON WANILDA DE — $34.7K across 9 shipments (17.1% of this supplier's total exports)
• GUILHERME MARTINS DE ALMEIDA — $17.1K across 4 shipments (8.4% of this supplier's total exports)
• LUIZ FRANCISCO GENRO SCHORN — $12.8K across 3 shipments (6.3% of this supplier's total exports)
• MARGARIDA ALVES DE SOUSA — $12.8K across 3 shipments (6.3% of this supplier's total exports)
Key Insight: NIVIRA EXPORTS operates with high shipment frequency (52 shipments) at a per-shipment value of $3.9K, indicating a broad distribution network with many smaller, regular orders.
3IKRIS PHARMA NETWORK PRIVATE LIMITED
IKRIS PHARMA NETWORK PRIVATE LIMITED is the third-largest Osimertinib exporter from India, with a market share of 12.0% and a total export value of $130.8K across 17 shipments. Their average shipment value of $7.7K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
IKRIS PHARMA NETWORK PRIVATE LIMITED serves 1 named buyer in our database. INDIRA GANDHI MEMORIAL HOSPITAL is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• INDIRA GANDHI MEMORIAL HOSPITAL — $130.8K across 17 shipments (100.0% of this supplier's total exports)
Key Insight: IKRIS PHARMA NETWORK PRIVATE LIMITED operates with high shipment frequency (17 shipments) at a per-shipment value of $7.7K, indicating a broad distribution network with many smaller, regular orders.
4MATSUN EXPORTS
MATSUN EXPORTS is the fourth-largest Osimertinib exporter from India, with a market share of 7.0% and a total export value of $76.3K across 14 shipments. Their average shipment value of $5.5K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
MATSUN EXPORTS serves 3 named buyers in our database. TO THE ORDER OF, is the dominant customer, accounting for 79.8% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF, — $60.9K across 11 shipments (79.8% of this supplier's total exports)
• TO THE ORDER OF, — $10.3K across 2 shipments (13.5% of this supplier's total exports)
• GERSON GOMES DE — $5.1K across 1 shipments (6.7% of this supplier's total exports)
Key Insight: MATSUN EXPORTS operates with high shipment frequency (14 shipments) at a per-shipment value of $5.5K, indicating a broad distribution network with many smaller, regular orders.
5VAMA LIFECARE PRIVATE LIMITED
VAMA LIFECARE PRIVATE LIMITED is the fifth-largest Osimertinib exporter from India, with a market share of 4.5% and a total export value of $49.5K across 9 shipments. Their average shipment value of $5.5K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
VAMA LIFECARE PRIVATE LIMITED serves 3 named buyers in our database. TO THE ORDER OF, is the dominant customer, accounting for 53.6% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF, — $26.5K across 5 shipments (53.6% of this supplier's total exports)
• TO THE ORDER OF, — $19.7K across 4 shipments (39.8% of this supplier's total exports)
• TO THE ORDER OF, — $3.3K across 1 shipments (6.6% of this supplier's total exports)
Key Insight: VAMA LIFECARE PRIVATE LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $5.5K, indicating a broad distribution network with many smaller, regular orders.
6YARAPMIN PHARMA PRIVATE LIMITED
YARAPMIN PHARMA PRIVATE LIMITED is the fifth-largest Osimertinib exporter from India, with a market share of 3.2% and a total export value of $35.4K across 15 shipments. Their average shipment value of $2.4K is below the market average of $8.4K, reflecting a high-volume, competitive pricing strategy.
YARAPMIN PHARMA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ADRIANE APARECIDA RODRIGUES DO NASC — $12.6K across 5 shipments (35.7% of this supplier's total exports)
• NAME:- EMIDIA TERCIA — $11.4K across 5 shipments (32.2% of this supplier's total exports)
• NAME:-ADRIANE APAREC — $3.8K across 2 shipments (10.7% of this supplier's total exports)
• NAME:- ADRIANE APARE — $3.8K across 2 shipments (10.7% of this supplier's total exports)
• NAME:-ADRIANE APAREC — $3.8K across 2 shipments (10.7% of this supplier's total exports)
Key Insight: YARAPMIN PHARMA PRIVATE LIMITED operates with high shipment frequency (15 shipments) at a per-shipment value of $2.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Osimertinib Flows
Once Osimertinib leaves the manufacturing plants of companies like NU HOSPITALS PRIVATE LIMITED and NIVIRA EXPORTS, it travels to 5 destination markets with a combined import value of $1.1M. Brazil absorbs the largest share at 56.9% ($620.3K), followed by United Kingdom (24.2%) and Maldives (12.0%).
In Brazil — the top destination — named importers include TO THE CONCERN PERSON, CONCERN PERSON WANILDA DE, TO THE.
This geographic spread reflects Osimertinib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Osimertinib Go? Top Importing Countries & Their Buyers
Trade flow of Osimertinib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil ranks as the first-largest destination for Osimertinib imports from India, with a total trade value of $620.3K across 44 shipments — representing a 56.9% share of all Osimertinib exports. The average shipment value of $14.1K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 12 tracked buyers.
Named Osimertinib importers in Brazil: TO THE CONCERN PERSON is the largest buyer, accounting for 20.2% ($125.4K) of this market's total imports.
• TO THE CONCERN PERSON — $125.4K (20.2% of Brazil's total)
• CONCERN PERSON WANILDA DE — $34.7K (5.6% of Brazil's total)
• TO THE — $17.2K (2.8% of Brazil's total)
Key Insight: Brazil's per-shipment average of $14.1K (68% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Osimertinib imports from India.
2United Kingdom
United Kingdom ranks as the second-largest destination for Osimertinib imports from India, with a total trade value of $264.1K across 0 shipments — representing a 24.2% share of all Osimertinib exports. The average shipment value of $264.1K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Kingdom's per-shipment average of $264.1K (3050% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Osimertinib imports from India.
3Maldives
Maldives ranks as the third-largest destination for Osimertinib imports from India, with a total trade value of $130.8K across 4 shipments — representing a 12.0% share of all Osimertinib exports. The average shipment value of $32.7K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Osimertinib importers in Maldives: INDIRA GANDHI MEMORIAL HOSPITAL is the largest buyer, accounting for 100.0% ($130.8K) of this market's total imports.
• INDIRA GANDHI MEMORIAL HOSPITAL — $130.8K (100.0% of Maldives's total)
Key Insight: Maldives's per-shipment average of $32.7K (290% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Maldives is a key market for Osimertinib imports from India.
4Bangladesh
Bangladesh ranks as the fourth-largest destination for Osimertinib imports from India, with a total trade value of $36.4K across 2 shipments — representing a 3.3% share of all Osimertinib exports. The average shipment value of $18.2K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Osimertinib importers in Bangladesh: INCEPTA PHARMACEUTICALS LTD is the largest buyer, accounting for 100.0% ($36.4K) of this market's total imports.
• INCEPTA PHARMACEUTICALS LTD — $36.4K (100.0% of Bangladesh's total)
Key Insight: Bangladesh's per-shipment average of $18.2K (117% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Bangladesh is a key market for Osimertinib imports from India.
5Lebanon
Lebanon ranks as the fifth-largest destination for Osimertinib imports from India, with a total trade value of $18.6K across 0 shipments — representing a 1.7% share of all Osimertinib exports. The average shipment value of $18.6K is above the global average of $8.4K, indicating high-value procurement contracts or branded formulations.
Key Insight: Lebanon's per-shipment average of $18.6K (122% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Lebanon is a key market for Osimertinib imports from India.
People Also Ask — Osimertinib Supplier & Trade Network
Who are the top suppliers of Osimertinib from India?+
Which companies buy Osimertinib from Indian manufacturers?+
Where does Osimertinib exported from India go?+
What is the market share of the top Osimertinib supplier from India?+
What is the average shipment value for Osimertinib exports from India?+
Is Osimertinib manufactured in India and exported globally?+
Which country imports the most Osimertinib from India?+
Who are the buyers of Osimertinib in United Kingdom?+
How concentrated is the Osimertinib supplier market in India?+
How do I find verified buyers for Osimertinib in specific countries?+
Osimertinib Trade Network — Key Takeaways
- 1NU HOSPITALS PRIVATE LIMITED is India's dominant Osimertinib exporter with a 24.2% market share and $264.1K in total exports — making it the single most important sourcing entity in this market.
- 2The top 15 suppliers collectively account for 69.6% of all tracked Osimertinib exports, with a combined trade value of $1.1M.
- 3Brazil is the largest destination market, absorbing 56.9% of India's Osimertinib exports ($620.3K). United Kingdom (24.2%) and Maldives (12.0%) follow.
- 4With 130 total shipments averaging $8.4K each, the Osimertinib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include TO THE CONCERN PERSON, CONCERN PERSON WANILDA DE, INDIRA GANDHI MEMORIAL HOSPITAL, GERSON GOMES DE — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 8 countries
Network value: $1.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Osimertinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Osimertinib.
- 2.Flow Mapping: 15 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 130 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 8 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
130 Verified Shipments
15 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists